PL2470228T3 - Sposoby i urządzenia do przeszczepiania komórek - Google Patents

Sposoby i urządzenia do przeszczepiania komórek

Info

Publication number
PL2470228T3
PL2470228T3 PL10751750T PL10751750T PL2470228T3 PL 2470228 T3 PL2470228 T3 PL 2470228T3 PL 10751750 T PL10751750 T PL 10751750T PL 10751750 T PL10751750 T PL 10751750T PL 2470228 T3 PL2470228 T3 PL 2470228T3
Authority
PL
Poland
Prior art keywords
methods
devices
cellular transplantation
transplantation
cellular
Prior art date
Application number
PL10751750T
Other languages
English (en)
Inventor
Craig Hasilo
Justin Leushner
Nicholas HAWORTH Daniel
Simon Shohet
Philip Michael Toleikis
Delfina Maria Mazzuca Siroen
Original Assignee
Sernova Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sernova Corporation filed Critical Sernova Corporation
Publication of PL2470228T3 publication Critical patent/PL2470228T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0282—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body with implanted tubes connected to the port
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
PL10751750T 2009-08-28 2010-08-27 Sposoby i urządzenia do przeszczepiania komórek PL2470228T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23801109P 2009-08-28 2009-08-28
EP10751750.0A EP2470228B1 (en) 2009-08-28 2010-08-27 Methods and devices for cellular transplantation
PCT/US2010/047028 WO2011025977A2 (en) 2009-08-28 2010-08-27 Methods and devices for cellular transplantation

Publications (1)

Publication Number Publication Date
PL2470228T3 true PL2470228T3 (pl) 2018-03-30

Family

ID=43466432

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10751750T PL2470228T3 (pl) 2009-08-28 2010-08-27 Sposoby i urządzenia do przeszczepiania komórek
PL17194182T PL3290061T3 (pl) 2009-08-28 2010-08-27 Sposoby i urządzenia do przeszczepiania komórek

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17194182T PL3290061T3 (pl) 2009-08-28 2010-08-27 Sposoby i urządzenia do przeszczepiania komórek

Country Status (26)

Country Link
US (5) US9011899B2 (pl)
EP (2) EP2470228B1 (pl)
JP (7) JP5756108B2 (pl)
KR (5) KR102057016B1 (pl)
CN (1) CN102596273B (pl)
AU (1) AU2010286531B2 (pl)
BR (1) BR112012004385B1 (pl)
CA (1) CA2772375C (pl)
CY (2) CY1119719T1 (pl)
DK (2) DK2470228T3 (pl)
EA (3) EA025142B1 (pl)
ES (2) ES2806645T3 (pl)
HK (1) HK1247860A1 (pl)
HR (2) HRP20171926T1 (pl)
HU (2) HUE036464T2 (pl)
IL (1) IL218360A (pl)
IN (1) IN2012DN02668A (pl)
LT (2) LT3290061T (pl)
MX (2) MX353390B (pl)
NO (1) NO2470228T3 (pl)
NZ (2) NZ598701A (pl)
PL (2) PL2470228T3 (pl)
PT (2) PT2470228T (pl)
SG (3) SG178565A1 (pl)
SI (2) SI3290061T1 (pl)
WO (1) WO2011025977A2 (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4176888A1 (en) 2008-11-14 2023-05-10 ViaCyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
SI3290061T1 (sl) * 2009-08-28 2020-09-30 Sernova Corporation Postopki in naprave za celično transplantacijo
EP2404672A1 (en) * 2010-07-06 2012-01-11 Universiteit Twente High troughput multiwell system for culturing 3D tissue constructs in-vitro or in-vivo, method for producing said multiwell system and methods for preparing 3D tissue constructs from cells using said multiwell system
MX2010013135A (es) * 2010-11-30 2012-05-31 Val De Bio S De R L De C V Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.
PL2964147T3 (pl) * 2013-03-07 2018-10-31 Viacyte, Inc. Trójwymiarowy zestaw urządzeń o dużej pojemności do kapsułkowania komórek
WO2014197798A2 (en) * 2013-06-07 2014-12-11 The Regents Of The University Of California Transplantation device and method of use
CN104195105B (zh) * 2014-08-19 2017-10-27 杭州安体科技有限公司 一种提高人精子活力的体外培养体系试剂盒及其使用方法
US10434122B2 (en) * 2014-09-24 2019-10-08 The Governors Of The University Of Alberta Cellular transplant site
CN107645952B (zh) 2015-03-23 2022-03-18 加利福尼亚大学董事会 薄膜细胞包囊装置
WO2017023379A1 (en) * 2015-08-06 2017-02-09 Lockheed Martin Corporation Implantable graphene membranes with low cytotoxicity
CA3005604C (en) * 2015-11-19 2023-07-18 Tepha, Inc. Methods to produce perforated collagen coated surgical meshes
JP2019521055A (ja) 2016-04-14 2019-07-25 ロッキード・マーチン・コーポレーション グラフェン欠陥の選択的界面緩和
US10967102B2 (en) 2016-09-28 2021-04-06 Boston Scientific Limited Cell encapsulation membranes, devices and methods
US11730696B2 (en) 2016-10-20 2023-08-22 Australian Foundation for Diabetes Research Cell associated scaffolds for delivery of agents
US11723558B2 (en) 2016-11-03 2023-08-15 Arizona Board Of Regents On Behalf Of The University Of Arizona Encapsulation device systems with oxygen sensors with or without exogenous oxygen delivery
WO2018102077A2 (en) * 2016-11-03 2018-06-07 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods, systems, and implantable devices for enhancing blood glucose regulation
CN115322880A (zh) 2016-11-03 2022-11-11 代表亚利桑那大学的亚利桑那董事会 用于在移植前后实时评估包封装置中细胞的方法和系统
US11052230B2 (en) * 2016-11-08 2021-07-06 W. L. Gore & Associates, Inc. Implantable encapsulation devices
US11623023B2 (en) 2016-11-10 2023-04-11 Viacyte, Inc. PDX1 pancreatic endoderm cells in cell delivery devices and methods thereof
US10993904B2 (en) * 2016-12-23 2021-05-04 Inscobee Inc. Transplantation implant for promoting hair growth
KR101952762B1 (ko) * 2017-05-08 2019-02-27 강원대학교산학협력단 알긴산과 콜라겐의 조합으로 생성된 줄기세포를 캡슐화하는 미세캡슐 조성물 및 그 제조방법
RU2663470C2 (ru) * 2017-05-11 2018-08-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Казанский государственный медицинский университет" Способ стимулирования ангиогенеза с использованием генетически модифицированных клеток крови пуповины
EP3409239A1 (en) 2017-05-29 2018-12-05 University College Dublin, National University of Ireland, Dublin An implantable active agent encapsulating device
CN107376033B (zh) * 2017-07-26 2019-03-26 湖南赛诺生物科技股份有限公司 一种细胞移植增效保护装置及其制备方法
JP7101377B2 (ja) 2017-09-15 2022-07-15 株式会社日立製作所 細胞培養基材、細胞培養容器、及び細胞培養方法
US11565094B2 (en) 2017-10-17 2023-01-31 The Methodist Hospital System Delivery devices
GB201717885D0 (en) * 2017-10-31 2017-12-13 Hothouse Medical Ltd Prothesis and method of manufacture
WO2019108973A2 (en) * 2017-11-30 2019-06-06 Duke University Compositions and methods for ablating niche cells in testis and other epithelial cells and methods relating thereto
CN112203667A (zh) * 2018-03-01 2021-01-08 塞拉克西斯股份有限公司 大包封的治疗性细胞、装置及其使用方法
RU2682160C2 (ru) * 2018-05-28 2019-03-15 Игорь Валерьевич Саматошенков Способ регенерации нервных волокон кровеносных сосудов
WO2020023957A1 (en) * 2018-07-27 2020-01-30 Washington University Cell-embedded vascular graft for transplantation
WO2020028885A1 (en) * 2018-08-02 2020-02-06 Georgetown University Methods and compositions for cell transplantation
WO2020041446A1 (en) 2018-08-22 2020-02-27 Boston Scientific Scimed Inc Cell encapsulation device including a porous tube
CA3114197C (en) * 2018-09-24 2023-10-03 Procyon Technologies Llc Methods and systems for implantable medical devices and vascularization membranes
WO2020138028A1 (ja) * 2018-12-25 2020-07-02 富士フイルム株式会社 細胞移植キット、袋状構造物の製造方法、および糖尿病治療剤
EP3962505A1 (en) 2019-05-01 2022-03-09 Sernova Corporation Methods of treating diabetes using devices for cellular transplantation
US20210093435A1 (en) 2019-09-27 2021-04-01 Isla Technologies, Inc. Bioartificial pancreas
BR112022013456A2 (pt) * 2020-01-13 2022-09-13 Incube Labs Llc Artigo de entrega de células; método de entrega de células a um sítio de tecido; e método de administração de células a um indivíduo
CN115443142A (zh) * 2020-02-10 2022-12-06 优美佳生物技术有限公司 胰岛移植装置、套件和方法

Family Cites Families (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3866609A (en) 1972-04-05 1975-02-18 Charles Howard Sparks Apparatus for growing graft tubes in place
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5786216A (en) * 1987-11-17 1998-07-28 Cytotherapeutics, Inc. Inner-supported, biocompatible cell capsules
WO1991000119A1 (en) * 1989-06-30 1991-01-10 Baxter International Inc. Implantable device
US5100392A (en) 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
US5733336A (en) 1990-10-31 1998-03-31 Baxter International, Inc. Ported tissue implant systems and methods of using same
WO1993008850A1 (en) 1991-10-30 1993-05-13 Massachusetts Institute Of Technology Prevascularized polymeric implants for organ transplantation
US6352707B1 (en) 1992-02-24 2002-03-05 Anton-Lewis Usala Transplant encapsulation in a hydrogel matrix to obscure immune recognition
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5425764A (en) 1992-07-30 1995-06-20 The University Of Toledo Bioartificial pancreas
US5262055A (en) 1992-10-19 1993-11-16 The University Of Utah Implantable and refillable biohybrid artificial pancreas
US6689608B1 (en) 1993-02-01 2004-02-10 Massachusetts Institute Of Technology Porous biodegradable polymeric materials for cell transplantation
CA2166116A1 (en) * 1993-06-23 1995-01-12 John F. Mills Method and apparatus for sealing implantable, membrane encapsulation devices
AU1561095A (en) * 1994-01-11 1995-08-01 Baxter International Inc. Ported tissue implant systems and methods of using same
US5686091A (en) * 1994-03-28 1997-11-11 The Johns Hopkins University School Of Medicine Biodegradable foams for cell transplantation
US5620883A (en) 1994-04-01 1997-04-15 The Johns Hopkins University Living cells microencapsulated in a polymeric membrane having two layers
ATE212230T1 (de) 1994-04-13 2002-02-15 Res Corp Technologies Inc Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
US5958404A (en) 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
US5849285A (en) 1994-04-13 1998-12-15 Research Corporation Technologies, Inc. Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US7018419B2 (en) 1994-05-20 2006-03-28 Spielberg Theodore E Microporous encapsulated endocrine cell disks, biconcave disks and multidimpled chambers for hormonal replacement
US20060263406A1 (en) 1994-07-01 2006-11-23 Lyles Mark B Implantable System for Cell Growth Control
US5853717A (en) * 1994-07-20 1998-12-29 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
GB9506844D0 (en) 1995-04-03 1995-05-24 Armitage Ian M Pharmaceutical microencapsulation
US5741334A (en) 1995-06-07 1998-04-21 Circe Biomedical, Inc. Artificial pancreatic perfusion device
EP0773753B1 (en) * 1995-06-07 2003-10-08 Gore Hybrid Technologies, Inc. An implantable containment apparatus for a therapeutical device
DE69634859D1 (de) 1995-10-26 2005-07-21 Paul P Latta Induktion von immunologischer toleranz
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US5881733A (en) 1996-09-13 1999-03-16 Depuy Orthopaedic Technology, Inc. Technique for osteocartilaginous transplantation in a mammalian joint
US6303136B1 (en) 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US7399751B2 (en) 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
US6716246B1 (en) 1998-12-15 2004-04-06 Universidad Nacional Autonoma De Mexico Process and device for facilitating the implantation of biological material
AU4476600A (en) 1999-04-22 2000-11-10 Vanderbilt University Polymeric encapsulation system promoting angiogenesis
US7371400B2 (en) 2001-01-02 2008-05-13 The General Hospital Corporation Multilayer device for tissue engineering
US7759113B2 (en) 1999-04-30 2010-07-20 The General Hospital Corporation Fabrication of tissue lamina using microfabricated two-dimensional molds
US20020151055A1 (en) 1999-11-02 2002-10-17 Stegemann Jan Philip Novel artificial pancreas
US6479066B1 (en) * 1999-12-16 2002-11-12 Rst Implanted Cell Technology, Llc Device having a microporous membrane lined deformable wall for implanting cell cultures
AU2001258091A1 (en) 2000-05-05 2001-11-20 Mcgill University A device for cell implantation
AU1112202A (en) * 2000-10-17 2002-04-29 Diatranz Ltd Preparation and xenotransplantation or porcine islets
US6517888B1 (en) 2000-11-28 2003-02-11 Scimed Life Systems, Inc. Method for manufacturing a medical device having a coated portion by laser ablation
US20050070883A1 (en) * 2000-11-29 2005-03-31 Brown James E Devices and methods for controlled delivery from a drug delivery device
US20020155559A1 (en) * 2001-01-17 2002-10-24 Laurencin Cato T. Biocompatible, biodegradable polymer-based, lighter than or light as water scaffolds for tissue engineering and methods for preparation and use thereof
US20030068308A1 (en) 2001-10-09 2003-04-10 Jacek Rozga Intrasplenic encapsulated cell therapy
TWI222997B (en) * 2001-12-10 2004-11-01 Ind Tech Res Inst Method for tissue culture in vitro
JP2003190259A (ja) 2001-12-28 2003-07-08 Hisako Ogawara 人工臓器用チャンバー
RU2240755C2 (ru) * 2002-02-26 2004-11-27 Колганов Андрей Сергеевич Устройство для имплантации клеточной культуры
US20030181978A1 (en) 2002-03-25 2003-09-25 Brown Kelly R. Channeled biomedical foams and method for producing same
AU2003285887B2 (en) 2002-10-11 2008-09-11 Novocell, Inc. Implantation of encapsulated biological materials for treating diseases
US7044965B1 (en) 2002-12-13 2006-05-16 Spielberg Theodore E Therapeutic cellular stent
US20040156878A1 (en) * 2003-02-11 2004-08-12 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
US20040197374A1 (en) * 2003-04-02 2004-10-07 Alireza Rezania Implantable pouch seeded with insulin-producing cells to treat diabetes
WO2005018540A2 (en) 2003-07-03 2005-03-03 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US8043614B2 (en) 2004-03-09 2011-10-25 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
WO2005072764A2 (en) 2004-01-16 2005-08-11 Novocell, Inc. Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
WO2005089673A1 (en) 2004-03-24 2005-09-29 Mika Lahtinen New product
BRPI0512685A (pt) 2004-07-29 2008-04-01 Univ Miami dispositivo hìbrido para terapias de célula
US9788978B2 (en) 2004-12-20 2017-10-17 Nicholas A. Rojo Implantable systems and stents containing cells for therapeutic uses
US20090028945A1 (en) 2005-06-04 2009-01-29 University Of Colorado Immunoisolative encapsulation system
ES2804472T3 (es) 2005-12-13 2021-02-08 Harvard College Estructuras para trasplante celular
WO2008008266A2 (en) 2006-07-07 2008-01-17 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Biohybrid elastomeric scaffolds and methods of use thereof
JP5214161B2 (ja) * 2006-07-10 2013-06-19 オリンパス株式会社 透過光学素子及びそれを用いた光学系
AU2007278850B2 (en) 2006-07-28 2013-06-06 Sertocell Biotechnology (Us) Corp. Adult sertoli cells and uses thereof
WO2008079997A2 (en) 2006-12-22 2008-07-03 Medtronic, Inc. Implantable device, angiogenesis mechanism and methods
EP2124815A1 (en) 2007-02-02 2009-12-02 University of Miami Therapeutic hybrid implantable devices
US7875072B2 (en) 2007-03-26 2011-01-25 Spielberg Theodore E Cellular transplant stent
EP2155810A4 (en) 2007-06-13 2013-07-03 Fmc Corp ALGINATE-COATED, POLYSAC-CHARIDE-CONTAINING FOAM COMPOSITE, MANUFACTURING METHOD AND USES THEREOF
US8821431B2 (en) 2007-09-07 2014-09-02 Beta O2 Technologies Ltd. Air gap for supporting cells
WO2009132173A2 (en) 2008-04-25 2009-10-29 Encapsulife, Inc. Immunoisolation patch system for cellular transplantation
US9540630B2 (en) 2008-09-17 2017-01-10 Beta O2 Technologies Ltd. Optimization of alginate encapsulation of islets for transplantation
US9446168B2 (en) 2010-06-07 2016-09-20 Beta-O2 Technologies Ltd. Multiple-layer immune barrier for donor cells
EP4176888A1 (en) 2008-11-14 2023-05-10 ViaCyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
EP2286822A1 (en) 2009-08-17 2011-02-23 Universiteit Twente Diabetes treatment
SI3290061T1 (sl) * 2009-08-28 2020-09-30 Sernova Corporation Postopki in naprave za celično transplantacijo
WO2011027221A1 (en) 2009-09-03 2011-03-10 Sernova Corporation Method of assessing islet function
US20130089594A1 (en) 2010-04-12 2013-04-11 Converge Biotech Inc. Macroporous bioengineered scaffolds for cell transplantation
EP2422823B1 (en) 2010-07-30 2014-03-19 Institut Quimic De Sarria Bioactive implant
FR2962898B1 (fr) 2010-07-22 2012-08-17 Statice Sante Poche pour former un organe artificiel implantable
US20120083767A1 (en) 2010-10-01 2012-04-05 The Johns Hopkins University Implantable bioreactor for delivery of paracrine factors
MX2010013135A (es) 2010-11-30 2012-05-31 Val De Bio S De R L De C V Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.
US8936650B2 (en) 2011-03-23 2015-01-20 The Regents Of The University Of California Mesh enclosed tissue constructs
US8579990B2 (en) 2011-03-30 2013-11-12 Ethicon, Inc. Tissue repair devices of rapid therapeutic absorbency
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
US10675138B2 (en) 2011-12-07 2020-06-09 The Trustees Of Princeton University Scaffolds for soft tissue and uses thereof
WO2013134360A1 (en) 2012-03-06 2013-09-12 The Uab Research Foundation Technologies for pancreatic islet transplantation
US9101707B2 (en) 2012-04-27 2015-08-11 Gregory Zeltser Implantable bioartificial perfusion system
US20140221982A1 (en) 2012-08-29 2014-08-07 Erik Gatenholm Semipermeable medical pouches and their uses
PL2964147T3 (pl) 2013-03-07 2018-10-31 Viacyte, Inc. Trójwymiarowy zestaw urządzeń o dużej pojemności do kapsułkowania komórek
US9950149B2 (en) 2013-04-24 2018-04-24 Nestec S.A. Biomolecular cell encapsulation device and methods of implantation
ES2649616T3 (es) 2013-06-17 2018-01-15 Hans U. Baer Matriz e implante para ingeniería de tejidos
AU2014318846A1 (en) 2013-09-11 2016-03-10 Neurotech Usa, Inc. Encapsulated cell therapy cartridge
EP3049020B1 (en) 2013-09-24 2022-06-15 Giner Life Sciences, Inc. System for gas treatment of a cell implant
FR3014316B1 (fr) 2013-12-10 2017-01-20 Defymed Organe bioartificiel
US10092507B2 (en) 2014-06-06 2018-10-09 Nanovault Medical Llc Implantable cellular and biotherapeutic agent delivery canister
US10434122B2 (en) 2014-09-24 2019-10-08 The Governors Of The University Of Alberta Cellular transplant site
CN108138127A (zh) 2015-08-14 2018-06-08 通用医疗公司 用于使用在活组织中提供连通的仿生结构的系统和方法
KR20180125937A (ko) 2015-08-17 2018-11-26 더 존스 홉킨스 유니버시티 조직 치유용 섬유-하이드로겔 복합체 외과용 메쉬
US10092387B2 (en) 2015-09-24 2018-10-09 California Institute Of Technology Implantable device for retaining live cells and providing nutrients thereto
US11338065B2 (en) 2015-10-08 2022-05-24 Massachusetts Institute Of Technology In situ expansion of engineered devices for regeneration
US20170105832A1 (en) 2015-10-15 2017-04-20 Kenneth Samuel Rosenblum Porous membrane structures and related techniques
WO2017083838A1 (en) 2015-11-12 2017-05-18 Biostage, Inc. Systems and methods for producing gastrointestinal tissues
AU2017269364B2 (en) 2016-05-25 2023-08-31 Salk Institute For Biological Studies Compositions and methods for organoid generation and disease modeling
WO2017218565A1 (en) 2016-06-14 2017-12-21 The Regents Of The University Of California Porous polymer scaffolds, and methods of making and using the same
EP3516040A1 (en) 2016-09-21 2019-07-31 Cellheal AS Implantable device and 3d bioprinting methods for preparing implantable device to deliver islets of langerhans
US10597639B2 (en) 2016-10-20 2020-03-24 Washington University 3D-printed scaffold device for cell transplantation
US11730696B2 (en) 2016-10-20 2023-08-22 Australian Foundation for Diabetes Research Cell associated scaffolds for delivery of agents
US10849731B2 (en) 2016-11-08 2020-12-01 W. L. Gore & Associates, Inc. Cell encapsulation devices containing structural spacers
US11338068B2 (en) 2016-11-08 2022-05-24 W. L. Gore & Associates, Inc. Two-part implantable therapy delivery device

Also Published As

Publication number Publication date
US10034963B2 (en) 2018-07-31
EA201992021A1 (ru) 2020-08-31
DK2470228T3 (en) 2018-01-02
HUE051328T2 (hu) 2021-03-01
JP2015157146A (ja) 2015-09-03
WO2011025977A3 (en) 2011-06-16
US20230347018A1 (en) 2023-11-02
JP2020089790A (ja) 2020-06-11
LT2470228T (lt) 2018-02-12
LT3290061T (lt) 2020-07-27
ES2806645T3 (es) 2021-02-18
SG178565A1 (en) 2012-04-27
PL3290061T3 (pl) 2020-11-02
SG10201405256VA (en) 2014-10-30
JP2013503014A (ja) 2013-01-31
WO2011025977A2 (en) 2011-03-03
JP2022082612A (ja) 2022-06-02
CY1119719T1 (el) 2018-06-27
KR102008762B1 (ko) 2019-08-09
MX353390B (es) 2018-01-10
NZ615383A (en) 2014-03-28
EP2470228B1 (en) 2017-10-04
KR20180124156A (ko) 2018-11-20
US20160151541A1 (en) 2016-06-02
JP2019005626A (ja) 2019-01-17
IL218360A (en) 2014-07-31
US11730860B2 (en) 2023-08-22
EP3290061A1 (en) 2018-03-07
EP2470228A2 (en) 2012-07-04
NZ598701A (en) 2014-03-28
EA201690437A1 (ru) 2016-10-31
EA033785B1 (ru) 2019-11-25
KR101785743B1 (ko) 2017-10-16
AU2010286531B2 (en) 2014-02-06
US10207026B2 (en) 2019-02-19
KR20190095516A (ko) 2019-08-14
AU2010286531A1 (en) 2012-04-05
KR20120091008A (ko) 2012-08-17
US20190240375A1 (en) 2019-08-08
BR112012004385A2 (pt) 2021-01-26
ES2653241T3 (es) 2018-02-06
JP2016163768A (ja) 2016-09-08
EA025142B1 (ru) 2016-11-30
PT3290061T (pt) 2020-07-20
KR20170117215A (ko) 2017-10-20
IN2012DN02668A (pl) 2015-09-04
KR102194187B1 (ko) 2020-12-22
EP3290061B1 (en) 2020-06-10
JP7416847B2 (ja) 2024-01-17
CN102596273A (zh) 2012-07-18
JP6446111B2 (ja) 2018-12-26
US20150209479A1 (en) 2015-07-30
KR102057016B1 (ko) 2019-12-17
EA201270337A1 (ru) 2012-10-30
CN102596273B (zh) 2014-11-05
JP5756108B2 (ja) 2015-07-29
JP2018043013A (ja) 2018-03-22
DK3290061T3 (da) 2020-07-13
US20120245705A1 (en) 2012-09-27
HUE036464T2 (hu) 2018-07-30
CY1123841T1 (el) 2022-03-24
KR101919728B1 (ko) 2018-11-16
JP5976883B2 (ja) 2016-08-24
SI3290061T1 (sl) 2020-09-30
MX2012002440A (es) 2012-06-19
HRP20171926T1 (hr) 2018-02-23
NO2470228T3 (pl) 2018-03-03
KR20190141017A (ko) 2019-12-20
SG10202001012VA (en) 2020-04-29
IL218360A0 (en) 2012-04-30
US9011899B2 (en) 2015-04-21
PT2470228T (pt) 2018-01-12
JP6676719B2 (ja) 2020-04-08
CA2772375A1 (en) 2011-03-03
SI2470228T1 (en) 2018-02-28
HRP20200982T1 (hr) 2020-11-27
HK1247860A1 (zh) 2018-10-05
BR112012004385B1 (pt) 2021-09-14
CA2772375C (en) 2020-06-30

Similar Documents

Publication Publication Date Title
HK1247860A1 (zh) 用於細胞移植的方法和設備
IL254144A0 (en) Methods for reprogramming cells and their use
EP2486664A4 (en) LISTING PROCESSING AND MOBILE DEVICE APPROVED THEREFOR
ZA201200038B (en) System and methods for through-the-earth communications
EP2497193A4 (en) SYSTEM AND METHOD FOR MOBILE INTERACTION
EP2426986A4 (en) PROCESS AND DEVICE FOR SWITCHING
EP2429624A4 (en) EXPANDABLE DEVICES AND METHOD THEREFOR
IL220261A0 (en) Intraocular devices and associated methods
EP2660988A4 (en) COMMUNICATION DEVICE AND COMMUNICATION METHOD
EP2629578A4 (en) COMMUNICATION DEVICE AND COMMUNICATION METHOD
EP2419049A4 (en) TRANSPLANTATION DEVICE
EP2471032A4 (en) COMPONENTS, SYSTEM AND METHODS FOR TRANSPORT SECURITY
EP2648136A4 (en) COMMUNICATION DEVICE AND COMMUNICATION PROCESS
EP2398291A4 (en) COMMUNICATION DEVICE AND COMMUNICATION PROCESS
SG10201405455UA (en) Cells and methods for obtaining them
EP2571193A4 (en) COMMUNICATION DEVICE AND METHOD
EP2510328A4 (en) SAMPLING DEVICES AND METHODS
AU334377S (en) Cellular phone
EP2466854A4 (en) MOBILE SEARCH METHOD AND ITS SYSTEM
GB2469889B (en) Systems and methods for communications
EP2419091A4 (en) NANOCANAL DEVICE AND RELATED METHODS
GB0912744D0 (en) Methods and uses
EP2590386A4 (en) TELEPHONE AND AUTOMATIC REDIAL REPRODUCTION METHOD THEREFOR
EP2396348A4 (en) METHOD FOR LEARNING A TRANSPLANT TOLERANCE
EP2470022A4 (en) COMPOUNDS AND METHODS